You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

CLINICAL TRIALS PROFILE FOR SYNERA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Synera

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00530803 ↗ The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children Completed Montefiore Medical Center Phase 2 2007-06-01 This study compares the efficacy of the Synera patch with Eutectic Mixture of Local Anesthetics (EMLA) as a topical anesthetic for venipuncture in pediatric patients.
NCT00564785 ↗ Synera™ for Epidural Needle Insertion Completed Duke University Phase 4 2007-02-01 We hypothesized that the analgesic effect of Synera™ analgesic patch would be superior to traditional infiltration with lidocaine for pain of epidural needle insertion in laboring parturients.
NCT00564785 ↗ Synera™ for Epidural Needle Insertion Completed IWK Health Centre Phase 4 2007-02-01 We hypothesized that the analgesic effect of Synera™ analgesic patch would be superior to traditional infiltration with lidocaine for pain of epidural needle insertion in laboring parturients.
NCT00747669 ↗ Pharmacokinetic Study of Synera™ in Neonates and Infants Suspended ZARS Pharma Inc. Phase 4 2008-09-01 This study will measure the amount of lidocaine and tetracaine in the blood after a 30 minute application of Synera.
NCT00891163 ↗ Evaluate the Depth and Duration of Anesthesia Completed Endo Pharmaceuticals Phase 4 2006-12-01 The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Synera

Condition Name

Condition Name for Synera
Intervention Trials
Pain 6
Healthy 2
Multiple Sclerosis 1
Shoulder Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Synera
Intervention Trials
Shoulder Impingement Syndrome 2
Syndrome 2
Osteoarthritis 1
Rotator Cuff Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Synera

Trials by Country

Trials by Country for Synera
Location Trials
United States 20
Canada 1
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Synera
Location Trials
Texas 3
Idaho 2
Kansas 2
North Carolina 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Synera

Clinical Trial Phase

Clinical Trial Phase for Synera
Clinical Trial Phase Trials
Phase 4 9
Phase 2 8
Phase 1/Phase 2 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Synera
Clinical Trial Phase Trials
Completed 16
Unknown status 2
Withdrawn 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Synera

Sponsor Name

Sponsor Name for Synera
Sponsor Trials
ZARS Pharma Inc. 8
Nuvo Research Inc. 4
The University of Texas Health Science Center, Houston 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Synera
Sponsor Trials
Other 17
Industry 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.